The activation of MEK-ERK signaling in the untreated ARAF p.S214C mutants was consistent with our in vitro findings, suggesting that enhanced tumor aggressiveness might be associated with increased MEK-ERK signaling. Here, MAP2K7 is linked to neoplasm.